Meds Apotek AB (STO:MEDS)
Sweden flag Sweden · Delayed Price · Currency is SEK
24.80
-0.60 (-2.36%)
At close: Jul 23, 2026

Meds Apotek AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
1,0931,018837.39659.97604.64
Revenue Growth (YoY)
16.43%21.59%26.88%9.15%-
Cost of Revenue
785.39728.21597.24468.14451.2
Gross Profit
307.21289.96240.16191.82153.45
Selling, General & Admin
283.74272.04227.38220.09244.36
Depreciation & Amortization Expenses
18.6120.1820.7520.6415.46
Other Operating Expenses
0.210.140.180.220.19
Total Operating Expenses
302.55292.37248.31240.94260.01
Operating Income
4.65-2.41-8.16-49.12-106.57
Interest Income
0.550.430.951.440
Interest Expense
-0.52-1.03-3.91-3.81-1.17
Total Non-Operating Income (Expense)
0.02-0.59-2.96-2.36-1.17
Pretax Income
4.67-3-11.11-51.48-107.74
Provision for Income Taxes
-10.29-10.73-0.71-0.461.77
Net Income
14.967.73-10.4-51.02-109.51
Net Income to Common
14.967.73-10.4-51.02-109.51
Net Income Growth
455.59%----
Shares Outstanding (Basic)
1818171715
Shares Outstanding (Diluted)
1918171715
Shares Change (YoY)
8.46%3.40%2.98%9.22%-
EPS (Basic)
0.820.44-0.60-3.05-7.14
EPS (Diluted)
0.800.43-0.60-3.05-7.14
EPS Growth
433.33%----
Free Cash Flow
8.23-21.8319.84-49.78-110.57
Free Cash Flow Per Share
0.44-1.221.15-2.97-7.21
Gross Margin
28.12%28.48%28.68%29.07%25.38%
Operating Margin
0.43%-0.24%-0.97%-7.44%-17.62%
Profit Margin
1.37%0.76%-1.24%-7.73%-18.11%
FCF Margin
0.75%-2.14%2.37%-7.54%-18.29%
EBITDA
4.6517.7812.6-28.49-106.57
EBITDA Margin
0.43%1.75%1.50%-4.32%-17.62%
EBIT
4.65-2.41-8.16-49.12-106.57
EBIT Margin
0.43%-0.24%-0.97%-7.44%-17.62%
Effective Tax Rate
-220.27%357.31%6.38%0.90%-1.64%